// App-Quantinova.ai

BSH2020‐PO‐132 : Implementing a venetoclax nursing care plan for a safe administration in a haematology setting

Researchers

Presenter

  • R. Bowen

Principal Investigators

  • A. Etherington

  • C. Bloodworth

  • N. Elmusharaf

Medical Centers

  • Haematology, Cardiff and Vale university health board, Cardiff, UK

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Chronic Lymphocytic Leukemia

  • Solid malignancies

Biomarkers

  • B-cell lymphoma 2

  • Breakpoint Cluster Region

Drug/Treatment

  • Venetoclax

  • Rituximab

Outcome

  • N/A

Study Design

  • Dose Escalation

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved